Supported Reaching + Abduction Loading for Stroke
(PRALINE Trial)
Trial Summary
What is the purpose of this trial?
This study attempts to minimize the development of a common movement impairment following stroke known as "flexion synergy" that makes it extremely difficult to reach outward with the arm. Participants with acute/subacute stroke will receive one of two study interventions in addition to prescribed therapies in both inpatient rehabilitation and day-rehab. Participants will be followed for 1 year.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Supported Reaching + Abduction Loading for Stroke?
Research shows that progressive abduction loading therapy, which is part of this treatment, helps improve arm movement in stroke patients by targeting muscle weakness and improving joint control. Studies found significant improvements in reaching distance and speed, suggesting this approach can effectively enhance arm function after a stroke.12345
Is Supported Reaching + Abduction Loading therapy safe for humans?
How does the treatment 'Supported Reaching + Abduction Loading' differ from other stroke treatments?
This treatment is unique because it combines progressive abduction loading with resistance training to specifically target and improve reaching function in stroke patients by addressing flexion synergy (abnormal muscle coordination) and muscle weakness, which are not typically the focus of standard stroke rehabilitation therapies.348910
Research Team
Michael D Ellis, PT, DPT
Principal Investigator
Northwestern University
Eligibility Criteria
This trial is for individuals aged 18-85 who've had a stroke within the last 90 days, can consent to participate, and have mild-to-moderate difficulty with language. They should have weakness on one side of their body but be able to follow simple commands with their unaffected arm. People with pre-existing disabilities in their arms, certain brain lesions, medical conditions that limit movement assessments, chronic neurological issues other than stroke, or pain that affects movement cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
In-patient Rehabilitation
Participants receive experimental or comparison group therapy as adjuvant to regular in-patient therapy. Sessions are conducted 5 days per week.
Day Rehabilitation
Participants continue to receive the same study intervention 3 days per week during day-rehabilitation.
Follow-up
Participants are monitored for safety and effectiveness after treatment with evaluations bimonthly until 12 months post-baseline.
Treatment Details
Interventions
- Abduction Loading
- Supported Reaching
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
Marianjoy Rehabilitation Hospital & Clinics
Collaborator
Shirley Ryan AbilityLab
Collaborator